Silgan (SLGN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Net sales for Q2 2026 reached $1.64 billion, up 7% year-over-year, driven by higher raw material cost pass-throughs, favorable FX, and strong volume growth in fragrance dispensing and pet food metal containers, partially offset by lower volumes in some segments.
Net income for Q2 2026 was $75.8 million ($0.72 per diluted share), down from $89.0 million ($0.83 per diluted share) in Q2 2025, with adjusted net income per diluted share at $0.98 versus $1.01 last year.
Adjusted EBIT for Q2 2026 was $185.3 million, down from $193.0 million in Q2 2025, reflecting margin pressures and higher rationalization charges.
Outperformed end-market trends in Dispensing and Specialty Closures and wet pet food Metal Containers.
Successfully executed a new long-term supply agreement in the vegetable market, resolving multi-year disruption.
Financial highlights
Gross profit margin declined to 17.9% in Q2 2026 from 19.4% in Q2 2025; gross profit was $294.9 million, slightly down from $299.1 million.
Adjusted EBIT was $185 million, down 4% year-over-year; Custom Containers up but Metal Containers down.
Adjusted EBITDA for Q2 2026 totaled $253.0 million, unchanged from Q2 2025.
Interest and other debt expense for Q2 2026 was $47.1 million, down year-over-year due to lower average debt.
Cash and cash equivalents at June 30, 2026 were $351.5 million, up from $317.5 million a year earlier.
Outlook and guidance
Full-year 2026 adjusted net income per diluted share estimated at $3.73 to $3.93, a 3% increase at midpoint over 2025.
Q3 2026 adjusted net income per diluted share guidance is $1.21 to $1.31, compared to $1.22 in Q3 2025.
Free cash flow for 2026 projected at approximately $450 million, including CapEx of ~$310 million.
Management expects sufficient liquidity from operations and credit facilities to meet all obligations and capital needs for the foreseeable future.
Volume growth expectations: low to mid-single digit for Dispensing and Specialty Closures, low single digit for Metal Containers and Custom Containers.
Latest events from Silgan
- Q1 2026 sales up 6.4%, adjusted EPS $0.78, and full-year guidance increased.SLGN
Q1 2026 - Proxy covers director elections, incentive plan amendment, auditor ratification, and say-on-pay.SLGN
Proxy filing - Record 2025 growth in key segments, with further earnings and cash flow gains expected in 2026.SLGN
Q4 2025 - Proxy covers director elections, auditor ratification, say-on-pay, and strong governance.SLGN
Proxy Filing - Q3 2024 saw record dispensing growth and Weener acquisition, setting up strong 2025 prospects.SLGN
Q3 2024 - €838M acquisition expands dispensing leadership, targets €20M synergies and 10% EPS accretion.SLGN
M&A Announcement - Q2 net sales fell 3.2% to $1.38B, but gross margin and adjusted EPS both increased.SLGN
Q2 2024 - Record Q1 2025 sales and earnings growth driven by Weener acquisition and volume gains.SLGN
Q1 2025 - Record Q4 results and 2025 double-digit growth outlook driven by acquisitions and dispensing demand.SLGN
Q4 2024